Interestingly, increased HDAC1 activity due to its phosphorylation by S6K1 at the downstream of mTORC1 signaling pathway has been shown to inhibit estrogen receptor-alpha expression; thus leading to therapy resistance in breast cancer (54). The gene discussed is RPS6KB1; the disease is breast carcinoma.